Immuron (IMRN) Current Deferred Revenue (2017 - 2023)
Immuron (IMRN) recorded quarterly Current Deferred Revenue of $466645.9 in Q2 2023, down 43.88% quarter-over-quarter from $831510.9 in Q2 2022, and down 43.88% on a YoY basis from $831510.9 in Q2 2022.
Immuron (IMRN) Current Deferred Revenue (2017 - 2023) Analysis & Trends
Immuron's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $466645.9 for Q2 2023.
- In Q2 2023, Current Deferred Revenue fell 43.88% year-over-year to $466645.9; the TTM figure through Jun 2023 stood at $466645.9 (down 43.88% YoY), while the FY2023 annual figure was $466645.9, down 43.88% from the prior year.
- Current Deferred Revenue was $466645.9 for Q2 2023 at Immuron, down from $831510.9 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $831510.9 in Q2 2022 to a low of $466645.9 in Q2 2023.
- Historically, Current Deferred Revenue has averaged $627413.0 across 3 years, with a median of $584082.2 in 2021.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue jumped 42.36% in 2022, then plunged 43.88% in 2023.
- A 3-year view of Current Deferred Revenue shows it stood at $584082.2 in 2021, then surged by 42.36% to $831510.9 in 2022, then slumped by 43.88% to $466645.9 in 2023.
- The last three Current Deferred Revenue figures came in at $466645.9 (Q2 2023), $831510.9 (Q2 2022), and $584082.2 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 466,645.92 |
| Jun 30, 2022 | 831,510.88 |
| Jun 30, 2021 | 584,082.20 |
| Dec 31, 2017 | 14,915.84 |
| Sep 28, 2017 | 15,094.98 |
| Aug 31, 2017 | 19,139.00 |
| Jun 30, 2017 | 14,377.41 |